Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
PUT
Hormel Foods
HRL
$13.9B
| $14.4M | ﹤0.01% |
606,200
+252,200
| +71% | +$5.89M |
|
2727
NatWest
NWG
$77.3B
| $14.4M | ﹤0.01% |
820,736
-792,136
| -49% | -$12.6M |
|
2728
PUT
Freshpet
FRPT
$2.93B
| $14.3M | ﹤0.01% |
235,200
+93,700
| +66% | +$5.31M |
|
|
NNE
2729
PUT
Nano Nuclear Energy
NNE
$944M
| $14.3M | ﹤0.01% |
596,700
+200
| +0% | +$7.66K |
|
2730
CVR Energy
CVI
$3.31B
| $14.3M | ﹤0.01% |
563,013
-526,000
| -48% | -$17.9M |
|
2731
La-Z-Boy
LZB
$1.64B
| $14.3M | ﹤0.01% |
384,098
+374,833
| +4,046% | +$13.1M |
|
|
SLNO
2732
DELISTED
Soleno Therapeutics
SLNO
| $14.3M | ﹤0.01% |
308,830
-141,296
| -31% | -$7.75M |
|
2733
CALL
Tilray
TLRY
$632M
| $14.3M | ﹤0.01% |
1,582,840
+902,790
| +133% | +$11M |
|
2734
PUT
Innodata
INOD
$2.07B
| $14.3M | ﹤0.01% |
280,500
-162,400
| -37% | -$10.6M |
|
2735
PUT
BioNTech
BNTX
$23.3B
| $14.3M | ﹤0.01% |
150,100
-98,300
| -40% | -$9.9M |
|
2736
Crescent Energy
CRGY
$3.77B
| $14.3M | ﹤0.01% |
1,702,159
+347,763
| +26% | +$3.05M |
|
2737
Schwab Fundamental International Small Company Index ETF
FNDC
$3.07B
| $14.3M | ﹤0.01% |
320,399
-19,830
| -6% | -$882K |
|
2738
PUT
Alexandria Real Estate Equities
ARE
$9.24B
| $14.3M | ﹤0.01% |
291,400
+126,200
| +76% | +$7.43M |
|
2739
Dillards
DDS
$9.57B
| $14.3M | ﹤0.01% |
23,518
-4,649
| -17% | -$2.93M |
|
2740
Avantor
AVTR
$9.25B
| $14.3M | ﹤0.01% |
1,243,956
-6,728,978
| -84% | -$82.8M |
|
2741
Castle Biosciences
CSTL
$928M
| $14.3M | ﹤0.01% |
366,356
+115,441
| +46% | +$3.72M |
|
|
BLSH
2742
CALL
Bullish
BLSH
$3.48B
| $14.2M | ﹤0.01% |
376,000
-1,248,100
| -77% | -$60.8M |
|
2743
PUT
CSX Corp
CSX
$92.3B
| $14.2M | ﹤0.01% |
392,200
-177,000
| -31% | -$6.33M |
|
2744
Algonquin Power & Utilities
AQN
$4.42B
| $14.2M | ﹤0.01% |
2,310,227
-2,134,899
| -48% | -$12.7M |
|
2745
Photronics
PLAB
$1.85B
| $14.2M | ﹤0.01% |
443,914
+191,332
| +76% | +$4.94M |
|
2746
Patterson-UTI
PTEN
$3.9B
| $14.2M | ﹤0.01% |
2,324,707
+1,646,870
| +243% | +$9.83M |
|
2747
Antero Resources
AR
$11.2B
| $14.2M | ﹤0.01% |
411,899
-1,144,004
| -74% | -$38.7M |
|
2748
Pegasystems
PEGA
$5.16B
| $14.2M | ﹤0.01% |
237,102
+147,492
| +165% | +$8.64M |
|
2749
Axcelis
ACLS
$4.03B
| $14.1M | ﹤0.01% |
176,047
+149,220
| +556% | +$12.5M |
|
2750
PUT
Capricor Therapeutics
CAPR
$243M
| $14.1M | ﹤0.01% |
490,000
-255,600
| -34% | -$3.34M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.